Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines

AccesswireFeb 26 08:00 ET

Express News | Telomir Pharmaceuticals Inc - Telomir-1 Reverses Calcium Dysregulation in Multiple Human Cell Lines

ReutersFeb 25 16:10 ET

Rodman & Renshaw Initiates Telomir Pharmaceuticals(TELO.US) With Buy Rating, Announces Target Price $15

Moomoo NewsFeb 21 04:31 ET · Ratings

Telomir Pharmaceuticals Initiated With a Buy at Rodman & Renshaw

TipRanksFeb 20 16:31 ET · Ratings

Express News | Telomir Pharmaceuticals Achieves Breakthrough In Silver Ion Stabilization, Says Unlocking A New Multi-Billion Dollar Medical Market

BenzingaFeb 20 16:01 ET

Telomir Pharmaceuticals Seeks To Tap Multi-Billion-Dollar Market With Breakthrough In Silver Ion Stabilization For Antibacterial Treatment, Tissue Regeneration

BenzingaFeb 20 16:01 ET

Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)

AccesswireFeb 18 08:00 ET

Express News | Telomir Pharmaceuticals Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing

ReutersFeb 14 17:01 ET

Telomir Pharmaceuticals | 10-K: FY2024 Annual Report

SECFeb 4 07:29 ET · Announcements

Telomir Pharmaceuticals Announces Results From Preclinical Studies of Telomir-1

TipRanksJan 28 08:30 ET

Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses

AccesswireJan 28 08:00 ET

Express News | Telomir Pharmaceuticals Inc - Telomir-1 Reverses Copper-Induced Ros Elevation in Human Cell Lines

ReutersJan 28 07:35 ET

Express News | Telomir Pharmaceuticals Inc - Announces Breakthrough Results With Telomir-1

ReutersJan 28 07:34 ET

Telomir Touts Potential of Telomir-1 in Addressing Oxidative Stress

Seeking AlphaJan 28 07:34 ET

Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) Biggest Owners Are Retail Investors Who Got Richer After Stock Soared 13% Last Week

Yahoo FinanceJan 16 09:51 ET

Renovaro Names Nathen Fuentes as CFO

MT NewswiresJan 7 10:02 ET

Telomir Pharmaceuticals Shares Are Trading Higher After the Company Announced Potentially Groundbreaking Findings From a Preclinical Progeria Lifespan Study.

BenzingaJan 7 08:49 ET

Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)

AccesswireJan 7 08:00 ET

Express News | Telomir Pharmaceuticals: Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria

ReutersJan 7 07:33 ET

Express News | Telomir Pharmaceuticals Inc - to Submit Ind & Inad Application by Q4 2025, With Clinical Trials Planned for 2026

ReutersDec 23, 2024 07:04 ET